Top Markets
#1 Siren Siren +45.54%
#2 Wrapped NXM Wrapped NXM +12.31%
#3 Cryptopia Cryptopia +9.12%
#4 Verus Coin Verus Coin +6.67%
#5 Mubarak Mubarak +6.18%
#6 Axelar Axelar +6.16%
#7 Notcoin Notcoin +5.51%
#8 OpenEden OpenEden +5.36%
#9 Stargate Finance Stargate Finance +4.89%
#10 Across Protocol Across Protocol +4.80%
Coin of the day
Siren Siren
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Intercept Pharmaceuticals, Inc. Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc.

ICPT
Classement en actions #12019
Intercept Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the... Intercept Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the advancement and market launch of therapies designed to treat progressive, non-viral liver conditions. Its operational reach spans the United States, Europe, and Canada. The company currently markets Ocaliva, a medication functioning as a farnesoid X receptor (FXR) agonist. This drug is approved for the treatment of primary biliary cholangitis (PBC) in adults, specifically when administered alongside ursodeoxycholic acid. Beyond its existing approved indications, Intercept is actively investigating Ocaliva's potential for additional uses, notably including nonalcoholic steatohepatitis (NASH). Concurrently, it is progressing other drug candidates through various clinical and preclinical stages of development. In a collaborative effort, the company holds a licensing agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. Intercept distributes its products through a dual approach, utilizing both its proprietary commercial organization and a network of external third-party distributors. The company was founded in 2002 and is headquartered in New York, New York.
Prix de l'action
$19.00
Dernière synchronisation: 2023-11-14
Capitalisation boursière
$629.64M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Intercept Pharmaceuticals, Inc. (ICPT)

Catégorie

Healthcare
Historique du prix de l'action pour Intercept Pharmaceuticals, Inc. (ICPT)
Prix de clôture le plus élevé : $18.99 le 2023-11-01

Prix de clôture le plus bas : $19.35 le 2012-10-01
Historique du prix de l'action de Intercept Pharmaceuticals, Inc. de 2012 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 39.35%
2022 -16.08%
2021 -46.76%
2020 -74.21%
2019 16.21%
2018 65.23%
2017 -41.82%
2016 -32.31%
2015 8.19%
2014 138.13%
2013 92.89%
2012 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.20 -12.94%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH